Distinguishing primary from secondary mucinous ovarian tumors: An algorithm using the novel marker DPEP1

Modern Pathology

Volumn 24, Issue 2, 2011, Pages 267-276

  Okamoto, Takako ^a   Matsumura, Noriomi ^a   Mandai, Masaki ^a   Oura, Tomonori ^b   Yamanishi, Yukio ^c   Horiuchi, Akiko ^d   Hamanishi, Junzo ^a   Baba, Tsukasa ^a   Koshiyama, Masafumi ^c   Shiozawa, Tanri ^d   Konishi, Ikuo ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^c OTSU RED CROSS HOSPITAL   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

differential diagnosis; dipeptidase 1(DPEP1); metastasis; mucinous adenocarcinoma; ovary

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CAUDAL TYPE HOMEOBOX 2 PROTEIN; CYTOKERATIN 20; CYTOKERATIN 7; DIPEPTIDASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HOMEODOMAIN PROTEIN; PROTEIN DPEP1; TUMOR MARKER; UNCLASSIFIED DRUG;

AGE; ALGORITHM; ARTICLE; CLINICAL PROTOCOL; CLUSTER ANALYSIS; COLORECTAL CANCER; DECISION TREE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; OVARY CANCER; OVARY METASTASIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; ALGORITHMS; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; DIPEPTIDASES; FEMALE; GASTROINTESTINAL NEOPLASMS; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79551650923     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.204     Document Type: Article

References (26)

1. Young RH, Scully RE. Metastatic tumors in the ovary: a problem-oriented approach and review of the recent literature. Semin Diagn Pathol 1991;8:250-276.
2. Young RH. From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor. Adv Anat Pathol 2006;13:205-227.
3. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003;27:985-993.
4. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol 2003;27:281-292.
5. McCluggage WG. Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 2002;40:309-326.
6. McCluggage WG. Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms. J Clin Pathol 2000;53:327-334.
7. McCluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 2005;47:231-247.
8. Vang R, Gown AM, Barry TS, et al. Cytokeratins 7 and .20. in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol 2006;30:1130-1139.
9. Vang R, Gown AM, Barry TS, et al. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol 2006;19:97-105.
10. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of .476. primary and metastatic carcinomas. Am J Surg Pathol 2003;27:303-310.
11. Yuan Y, Nymoen DA, Dong HP, et al. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions. Hum Pathol 2009;40:1453-1460.
12. Lagendijk JH, Mullink H, Van Diest PJ, et al. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 1998;29:491-497.
13. Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 2008;32:1566-1571.
14. Moritani S, Ichihara S, Hasegawa M, et al. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis? Hum Pathol 2008;39:666-671.
15. Heinzelmann-Schwarz VA, Scolyer RA, Scurry JP, et al. Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries. J Clin Pathol 2007;60:622-626.
16. Lau SK, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol 2004;122:61-69.
17. Yajima S, Ishii M, Matsushita H, et al. Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer. Int J Oncol 2007;31:1029-1037.
18. McIver CM, Lloyd JM, Hewett PJ, et al. Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma. Cancer Lett 2004;209:67-74.
19. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinaltype mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999;23:617-635.
20. Ronnett BM, Kurman RJ, Shmookler BM, et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 1997;21:1144-1155.
21. Kozak EM, Tate SS. Glutathione-degrading enzymes of microvillus membranes. J Biol Chem 1982;257: 6322-6327.
22. Vang R, Gown AM, Wu LS, et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol 2006;19:1421-1428.
23. Liu M, Matsumura N, Mandai M, et al. Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression. Mod Pathol 2009;22:373-384.
24. Prasad ML, Barbacioru CC, Rawal YB, et al. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Mod Pathol 2008;21:105-114.
25. Yemelyanova AV, Vang R, Judson K, et al. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol 2008;32: 128-138.
26. Antila R, Jalkanen J, Heikinheimo O. Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics. Gynecol Oncol 2006;101:97-101.